Abstract:The development of CRISPR-based gene-editing technologies has brought an unprecedented revolution in the field of genome engineering. Cas12a, a member of the Class 2 Type V CRISPR-associated endonuclease family distinct from Cas9, has been repurposed and developed into versatile gene-editing tools with distinct PAM recognition sites and multiplexed gene targeting capability. However, with current CRISPR/Cas12a technologies, it remains a challenge to perform efficient and precise genome editing of long sequences in mammalian cells. To address this limitation, we utilized phage recombination enzymes and developed an efficient CRISPR/Cas12a tool for multiplexed precision editing in mammalian cells. Through protein engineering, we were able to recruit phage recombination proteins to Cas12a to enhance its homology-directed repair efficiencies. Our phage-recombination-assisted Cas12a system achieved up to 3-fold improvements for kilobase-scale knock-ins in human cells without compromising the specificity of the enzyme. The performance of this system compares favorably against Cas9 references, the commonly used enzyme for gene-editing tasks, with improved specificity. Additionally, we demonstrated multi-target editing with similar improved activities thanks to the RNA-processing activity of the Cas12a system. This compact, multi-target editing tool has the potential to assist in understanding multi-gene interactions. In particular, it paves the way for a gene therapy method for human diseases that complements existing tools and is suitable for polygenic disorders and diseases requiring long-sequence corrections.

CRISPR beyond: harnessing compact RNA-guided endonucleases for enhanced genome editing

SgRNA Engineering for Improved Genome Editing and Expanded Functional Assays.

CRISPR-Cas12a System With Synergistic Phage Recombination Proteins for Multiplex Precision Editing in Human Cells

Miniature CRISPR-Cas12 Systems: Mechanisms, Engineering, and Genome Editing Applications

To Cut or Not to Cut: Next-generation Genome Editors for Precision Genome Engineering

Programmed genome editing by a miniature CRISPR-Cas12f nuclease

Advances in miniature CRISPR-Cas proteins and their applications in gene editing

Long sequence insertion via CRISPR/Cas gene-editing with transposase, recombinase, and integrase

Next-generation CRISPR technology for genome, epigenome and mitochondrial editing

Genome editing with CRISPR–Cas nucleases, base editors, transposases and prime editors

Cas9-Based Tools For Targeted Genome Editing And Transcriptional Control

CRISPR-Cas systems for editing, regulating and targeting genomes

Advancing CRISPR base editing technology through innovative strategies and ideas

Recent application of CRISPR-Cas12 and OMEGA system for genome editing

CRISPR technologies for genome, epigenome and transcriptome editing

Prime editing for precise and highly versatile genome manipulation

Engineered miniature CRISPR-Cas system for mammalian genome regulation and editing

The application of CRISPR /Cas mediated gene editing in synthetic biology: Challenges and optimizations

CRISPR/Cas9 in Genome Editing and Beyond

CRISPR/Cas9 Systems: The Next Generation Gene Targeted Editing Tool

CRISPER/CAS: A potential tool for genomes editing